Prediction of extraprostatic cancer by serum [-2] pro prostate specific antigen in clinically localized prostate cancer

被引：0
|
作者：
Nakashima, Jun
Yamazaki, Keiichi
Kikuchi, Eiji
Miyajima, Akira
Nakagawa, Ken
Oya, Mototsugu
Ohigashi, Takashi
Murai, Masaru
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31367-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [1] Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy gleason score in clinically localized prostate cancer
    Horiguchi, A
    Nakashima, J
    Horiguchi, Y
    Nakagawa, K
    Oya, M
    Ohigashi, T
    Marumo, K
    Murai, M
    PROSTATE, 2003, 56 (01): : 23 - 29
  • [2] Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer
    Nishimoto, Koshiro
    Nakashima, Jun
    Hashiguchi, Akinori
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Ohigashi, Takashi
    Oya, Mototsugu
    Murai, Masaru
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (06) : 520 - 523
  • [3] The role of prostate specific antigen in screening and management of clinically localized prostate cancer
    Khurshid Gurui
    Ashutosh Tewari
    Ashok K. Hemal
    John Wei
    Javid Javidan
    James Peabody
    Mani Menon
    International Urology and Nephrology, 2003, 35 (1) : 107 - 113
  • [4] Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer
    Zagars, GK
    Pollack, A
    RADIOTHERAPY AND ONCOLOGY, 1997, 44 (03) : 213 - 221
  • [5] Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
    Bjork, T
    Piironen, T
    Pettersson, K
    Lovgren, T
    Stenman, UH
    Oesterling, JE
    Abrahamsson, PA
    Lilja, H
    UROLOGY, 1996, 48 (06) : 882 - 888
  • [6] The use of percent free prostate specific antigen for staging clinically localized prostate cancer
    Pannek, J
    Rittenhouse, HG
    Chan, DW
    Epstein, JI
    Walsh, PC
    Partin, AW
    JOURNAL OF UROLOGY, 1998, 159 (04): : 1238 - 1242
  • [7] THE SOURCE OF PRETREATMENT SERUM PROSTATE-SPECIFIC ANTIGEN IN CLINICALLY LOCALIZED PROSTATE-CANCER - T, N, OR M
    ZAGARS, GK
    KAVADI, VS
    POLLACK, A
    VONESCHENBACH, AC
    SANDS, ME
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (01): : 21 - 32
  • [8] Value of percent free prostate-specific antigen for the prediction of pathological stage in men with clinically localized prostate cancer
    Morote, J
    Trilla, E
    Esquena, S
    Serrallach, F
    Abascal, JM
    H'Mammed, YI
    de Torres, IM
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (04): : 239 - 243
  • [9] The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Fondurulia, J
    Chen, MH
    Tomaszewski, JE
    Wein, A
    JOURNAL OF UROLOGY, 1998, 160 (06): : 2096 - 2101
  • [10] PROSTATE-SPECIFIC ANTIGEN AND RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    ZAGARS, GK
    POLLACK, A
    KAVADI, VS
    VONESCHENBACH, AC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02): : 293 - 306
12345